NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Merz Raleigh HQ
Xeomin, a botulinum toxin similar to Botox that is used cosmetically to smooth frown lines between the eyebrows, is becoming an ever more versatile product for Raleigh-based Merz North America. The FDA just approved it to treat chronic sialorrhea, or excessive drooling, in adults. 
proinnovera logo
North Carolina’s reputation as the global epicenter for contract research organizations (CROs) has been boosted with the Wilmington opening of an office by German CRO proinnovera GmbH.
A new study conducted by researchers from Duke University, MIT and Singapore’s Nanyang Technological University shows that sound waves are capable of rapidly and efficiently separating circulating tumor cells (CTCs) from blood.
Participants socialize at NCBiotech
Even the best scientific innovation can be flattened by public distrust. That was the major reminder from Kevin Folta, Ph.D., a professor of horticultural sciences at the University of Florida, to dozens of people gathered at the North Carolina Biotechnology Center Wednesday. 
PMWC logo
Professionals involved in the field of precision health have until September 14 to use a special discount code when registering to attend the September 24 and 25 Precision Medicine World Conference 2018 (PMWC) at Duke University’s Fuqua School of Business.
LabCorp logo
Burlington-based LabCorp has received approval from the U.S. Food and Drug Administration to market a diagnostic test that can detect four viruses in donated blood plasma used in making biologic therapies.
Greenwich Biosciences logo
A British company with U.S. headquarters in Research Triangle Park has become the first to receive U.S. Food and Drug Administration approval for a prescription drug derived from marijuana.
Precision Biosciences logo
Durham-based genome editing company Precision BioSciences announced that it has raised $110 million to further the development of its proprietary ARCUS genome editing platform.
Istari logo
Istari Oncology, a young Research Triangle Park biotechnology company started by a world-famous Duke University brain cancer team, has reported rare positive results in a Phase 1 clinical trial of its experimental treatment for glioblastoma.
Foundation, Roche logos
North Carolina’s global precision health and gene therapy profile got a boost this week with the announcement that Swiss drug giant Roche will add $2.4 billion to the $1 billion it already invested, to buy gene testing company Foundation Medicine.
DRIVE logo
Startups, small businesses and incubators developing solutions for health security needs are invited to a U.S. Department of Health and Human Services pre-proposal Webex conference call on Friday, June 22, at First Flight Venture Center in Research Triangle Park. 
Glenmark Monroe pharma manufacturing facility
Glenmark Pharmaceuticals, an India-based global pharmaceutical company, has received its first U.S. Food and Drug Administration go-ahead to market one of its North Carolina-made drugs in the United States.
Wilmington Fire Dept. Marine 1 vessel
Durham-based Alcami has donated $15,000 to the Wilmington Fire Department to help fund IvyGene cancer screenings for firefighters, who face above-average risk of developing cancer.
Chiesi logo
​​​​​​​Chiesi USA of Cary and its European partner Holostem Terapie Avanzate have received Orphan Drug Designation from the U.S. Food and Drug Administration for an investigational cell-based therapy for a rare eye disease.
SBIR logo
Small North Carolina technology firms, innovators, scientists and researchers will have the opportunity on June 21 and 22 to learn more about the U.S. Small Business Administration’s grant programs.